Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study

2010156 citationsJournal Article

Authors

Richard G Armstrong · United Lincolnshire Hospitals NHS Trust

Abstract

We found evidence of an increased risk of lymphoma, which is consistent with previous studies. We found no overall increase in risk of cancer in individuals with IBD who had taken azathioprine. Our study does not show a need for azathioprine cessation in the medium term in IBD because of the risk of malignancy.

Topics & Keywords

Inflammatory Bowel Disease Gastrointestinal disorders and treatments Chronic Lymphocytic Leukemia Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Gastroenterology

Volume 105, Issue 7, pp. 1604-1609

DOI: 10.1038/ajg.2009.745

Field-Weighted Citation Impact: 10.00